Similar to that seen for the association between IL-17 and leptin, there was a significant relationship between levels of IL-6 and leptin in HNSCC patients that had received 1,25(OH)2D3 treatment (Figure 4, right panel; r = 0.790, p < 0.0001). This evidence concerns the gene LEP and head and neck squamous cell carcinoma.